User profiles for C. V. Arancibia-Cárcamo
Carolina ArancibiaVerified email at ucl.ac.uk Cited by 7681 |
[HTML][HTML] Innate lymphoid cells in intestinal inflammation
A Geremia, CV Arancibia-Cárcamo - Frontiers in immunology, 2017 - frontiersin.org
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the intestine that
encompasses Crohn’s disease (CD) and ulcerative colitis. The cause of IBD is unknown, but the …
encompasses Crohn’s disease (CD) and ulcerative colitis. The cause of IBD is unknown, but the …
A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β– and retinoic acid–dependent mechanism
…, KRR Siddiqui, CV Arancibia-Cárcamo… - The Journal of …, 2007 - rupress.org
Foxp3 + regulatory T (T reg) cells play a key role in controlling immune pathological re
actions. Many develop their regulatory activity in the thymus, but there is also evidence for …
actions. Many develop their regulatory activity in the thymus, but there is also evidence for …
[PDF][PDF] Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was
introduced in the United Kingdom to accelerate population coverage with a single dose. At this …
introduced in the United Kingdom to accelerate population coverage with a single dose. At this …
[PDF][PDF] The short chain fatty acid butyrate imprints an antimicrobial program in macrophages
Host microbial cross-talk is essential to maintain intestinal homeostasis. However, maladaptation
of this response through microbial dysbiosis or defective host defense toward invasive …
of this response through microbial dysbiosis or defective host defense toward invasive …
IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease
A Geremia, CV Arancibia-Cárcamo… - Journal of Experimental …, 2011 - rupress.org
… Geremia and CV Arancibia-Cárcamo contributed equally to … Program of the Broad Foundation
(CV Arancibia-Cárcamo). … Geremia and CV Arancibia-Cárcamo contributed equally to …
(CV Arancibia-Cárcamo). … Geremia and CV Arancibia-Cárcamo contributed equally to …
[PDF][PDF] Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis
A Izcue, S Hue, S Buonocore, CV Arancibia-Cárcamo… - Immunity, 2008 - cell.com
Interleukin-23 (IL-23) is an inflammatory cytokine that plays a key role in the pathogenesis
of several autoimmune and inflammatory diseases. It orchestrates innate and T cell-mediated …
of several autoimmune and inflammatory diseases. It orchestrates innate and T cell-mediated …
[PDF][PDF] A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Treatment of severe COVID-19 is currently limited by clinical heterogeneity and incomplete
description of specific immune biomarkers. We present here a comprehensive multi-omic …
description of specific immune biomarkers. We present here a comprehensive multi-omic …
Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity
…, Y Lee, JD Trombley, CV Arancibia-Cárcamo… - Journal of Experimental …, 2015 - rupress.org
Cytotoxic T lymphocyte antigen-4 (CTLA-4) is an essential negative regulator of T cell
responses. Germline Ctla4 deficiency is lethal, making investigation of the function of CTLA-4 on …
responses. Germline Ctla4 deficiency is lethal, making investigation of the function of CTLA-4 on …
[PDF][PDF] TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions
…, S McCuaig, M Neyazi, CV Arancibia-Cárcamo… - Cell reports, 2019 - cell.com
MAIT cells are an unconventional T cell population that can be activated through both TCR-dependent
and TCR-independent mechanisms. Here, we examined the impact of …
and TCR-independent mechanisms. Here, we examined the impact of …
[HTML][HTML] T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses
Identification of protective T cell responses against SARS-CoV-2 requires distinguishing
people infected with SARS-CoV-2 from those with cross-reactive immunity to other …
people infected with SARS-CoV-2 from those with cross-reactive immunity to other …